Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Beam Therapeutics
BEAM
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$26.00
0.35
1.36%
Pre-Market: Sep 20, 5:29 PM EDT
15 minutes delayed
Get Report
Comment
Beam Therapeutics (BEAM) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Beam Therapeutics (NASDAQ:BEAM) Stock
Beam Therapeutics Stock (NASDAQ: BEAM)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, September 19, 2024
RBC Capital Reiterates Sector Perform on Beam...
Benzinga Newsdesk
Tuesday, September 17, 2024
Jones Trading Initiates Coverage On Beam Ther...
Benzinga Newsdesk
Wednesday, September 11, 2024
Deep Dive Into Beam Therapeutics Stock: Analyst Perspectives (6 Ratings)
Benzinga Insights
Stifel Maintains Buy on Beam Therapeutics, Ra...
Benzinga Newsdesk
Thursday, August 22, 2024
A Closer Look at 5 Analyst Recommendations For Beam Therapeutics
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Beam Th...
Benzinga Newsdesk
Wednesday, August 14, 2024
Gene Editing Korro Bio's Preclinical Data 'Best-In-Class', Analyst Initiates With Outperform Rating
Vandana Singh
Wednesday, August 07, 2024
JP Morgan Maintains Overweight on Beam Therap...
Benzinga Newsdesk
Barclays Maintains Equal-Weight on Beam Thera...
Benzinga Newsdesk
RBC Capital Reiterates Sector Perform on Beam...
Benzinga Newsdesk
Tuesday, August 06, 2024
Beam Therapeutics Says Ended Q2 2024 With $1....
Benzinga Newsdesk
Beam Therapeutics Q2 2024 GAAP EPS $(1.11) Be...
Benzinga Newsdesk
Sunday, July 28, 2024
ViaSat & AST SpaceMobile Are Among Top 6 Mid Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
Lekha Gupta
Thursday, July 25, 2024
IBM Posts Upbeat Earnings, Joins ServiceNow, Helmerich & Payne, RTX, Nasdaq And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Tuesday, July 23, 2024
Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Beam Therapeutics shares are trading higher a...
Benzinga Newsdesk
HC Wainwright & Co. Initiates Coverage On Bea...
Benzinga Newsdesk
Friday, July 19, 2024
Cathie Wood-Led Ark Invest Sells $8M In Tesla Shares Despite Bullish Autonomy Forecast
Benzinga Neuro
Monday, July 15, 2024
Beam Therapeutics Has Initiated A Search For ...
Benzinga Newsdesk
Friday, July 12, 2024
Here's Why You Should Invest in Beam Therapeutics Now
Zacks
Thursday, June 27, 2024
Beam Therapeutics Begins Dosing in Phase I/II AATD Study
Zacks
Wednesday, June 26, 2024
Beam Therapeutics Announced The First Patient...
Benzinga Newsdesk
Friday, June 14, 2024
Beam Therapeutics Highlights Improved Manufac...
Benzinga Newsdesk
Tuesday, May 14, 2024
Beam Therapeutics Presents Data Highlighting ...
Benzinga Newsdesk
Wednesday, May 08, 2024
Barclays Maintains Equal-Weight on Beam Thera...
Benzinga Newsdesk
Tuesday, May 07, 2024
Beam Therapeutics Ended Q1 2024 With $1.1B In...
Benzinga Newsdesk
Beam Therapeutics Q1 2024 GAAP EPS $(1.21) Be...
Benzinga Newsdesk
Tuesday, April 23, 2024
Expert Ratings For Beam Therapeutics
Benzinga Insights
Wedbush Reiterates Outperform on Beam Therape...
Benzinga Newsdesk
Friday, April 12, 2024
Popular Crypto Trader Shares 2024 Predictions For These Three Altcoins
Murtuza Merchant
Tuesday, April 02, 2024
Beam Therapeutics shares are trading lower af...
Benzinga Newsdesk
Gene Therapy Side Effects: Verve Therapeutics Halts Enrollment Of Lead Gene Therapy Trial In Patients With Bad Cholesterol
Vandana Singh
Wednesday, March 27, 2024
Expert Outlook: Beam Therapeutics Through The Eyes Of 4 Analysts
Benzinga Insights
BMO Capital Maintains Outperform on Beam Ther...
Benzinga Newsdesk
Tuesday, March 26, 2024
Beam Therapeutics Announces Clearance of Clin...
Benzinga Newsdesk
Wednesday, February 28, 2024
Navigating 4 Analyst Ratings For Beam Therapeutics
Benzinga Insights
RBC Capital Maintains Sector Perform on Beam ...
Benzinga Newsdesk
Tuesday, February 27, 2024
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Norwegian Cruise Line Posts Strong Sales, Joins Hims & Hers Health, Sterling Infrastructure And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Beam Therapeutics shares are trading higher a...
Benzinga Newsdesk
Recap: Beam Therapeutics Q4 Earnings
Benzinga Insights
Beam Therapeutics Q4 EPS $1.73 Vs $(0.54) YoY...
Benzinga Newsdesk
Friday, February 09, 2024
Cathie Wood Trims Nvidia, Shopify Stakes To Pump Whopping $40M Into Pinterest Despite Q4 Revenue Miss
Benzinga Neuro
Monday, January 29, 2024
JP Morgan Upgrades Beam Therapeutics to Overw...
Benzinga Newsdesk
Wednesday, January 17, 2024
Bitcoin, Ethereum, Dogecoin Rise As Investors Weigh Spot ETF Impact: Analyst Says Scenario For King Crypto Is 'Rejection' At $46K And Then Correction To Below $40K
Mehab Qureshi
Monday, January 08, 2024
Beam Therapeutics Reports Progress Across Hem...
Benzinga Newsdesk
Friday, December 15, 2023
B of A Securities Downgrades Beam Therapeutic...
Benzinga Newsdesk
Friday, December 08, 2023
Beam Therapeutics shares are trading lower af...
Benzinga Newsdesk
Lululemon To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Friday
Avi Kapoor
Jefferies Downgrades Beam Therapeutics to Hol...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch